{"id":332762,"date":"2026-10-29T17:12:30","date_gmt":"2026-10-29T11:42:30","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q2-results-fy27-pat-54-crore\/"},"modified":"2026-10-29T17:12:30","modified_gmt":"2026-10-29T11:42:30","slug":"indraprastha-medical-corporation-q2-results-fy27-pat-54-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/indraprastha-medical-corporation-q2-results-fy27-pat-54-crore\/","title":{"rendered":"Indraprastha Medical Corporation Q2 Results FY27: PAT Rises 8.33% to Rs 53.58 Cr, Revenue Rs 412.85 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Indraprastha Medical Corporation Q2 Results FY27 were declared on 29 October 2026 on a Standalone basis. Revenue rose 8.35% to Rs 412.85 Cr from Rs 381.03 Cr a year earlier, while net profit grew 8.33% to Rs 53.58 Cr from Rs 49.46 Cr. These quarterly results also show Operating Profit up 8.6% to Rs 77.44 Cr, so YoY growth is steady across all three lines.<\/p>\n<\/div>\n

Indraprastha Medical Corporation Ltd<\/a> (INDRAMEDCO) Q2 Results FY27 announced on 29 October 2026, covering the company’s financial performance for the July to September quarter. The results date brought standalone results with revenue of Rs 412.85 Cr and PAT of Rs 53.58 Cr, and Indraprastha Medical Corporation Q2 Results FY27 show revenue 8.35% higher than the same quarter last year on a Standalone basis.<\/p>\n

Indraprastha Medical Corporation Q2 Results are examined here through a results analysis that covers the financial highlights, business drivers, outlook and risks. The figures below set out how revenue, Operating Profit and net profit moved against the same quarter last year, starting with the Financial Highlights table.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n